IPWatchdog

When Did Medical Innovation Become a Bad Thing?

Congress has been holding hearings on pharmaceutical patents and drug prices, along with U.S. Patent and Trademark Office (USPTO) fee-setting and oversight. During these hearings, America's pharmaceutical innovators face an unusual criticism: They are accused of abusing the patent system not only when they invent new medicines, but also when they improve them. The post When Did Medical Innovation Become a Bad Thing? appeared first on IPWatchdog.com | Patents & Intellectual Property Law.

By IPWatchdog

1 min read
When Did Medical Innovation Become a Bad Thing?
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Intellectual Property Law

Related Insights